4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-005790
Options or other derivatives
- Chief Financial Officer acquired 61,822 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Musso Alan A Chief Financial Officer | 2024-01-17 | Grant or award · Stock Option (right to buy) | +61,822 | 61,822 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…